Mice lacking the IL-22 receptor are more susceptible to HFD-induced obesity and IR, and treatment of obese mice with IL-22 suppresses TNF expression in adipose tissue, as well as improving IR [148]. This evidence concerns the gene IL22 and obesity due to melanocortin 4 receptor deficiency.